Evidence map›Paper›PMID 27875258›Full record

ArticleJournal of lipid research2017

Sweat lipid mediator profiling: a noninvasive approach for cutaneous research.

Karan Agrawal, Lauren A Hassoun, Negar Foolad, Theresa L Pedersen, Raja K Sivamani, John W Newman

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Sweat components as a promising monitoring tool for systemic diseases.The journal of physiological sciences : JPS · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Karan AgrawalDepartment of Nutrition, University of California-Davis, Davis, CA 95616.ORCID 0000-0002-9536-9489
Lauren A HassounDepartment of Dermatology, University of California-Davis Medical Center, Sacramento, CA 95816.
Negar FooladDepartment of Dermatology, University of California-Davis Medical Center, Sacramento, CA 95816.
Theresa L PedersenNational Institutes of Health West Coast Metabolomics Center, Davis, CA 95616.
Raja K SivamaniDepartment of Dermatology, University of California-Davis Medical Center, Sacramento, CA 95816.
John W NewmanDepartment of Nutrition, University of California-Davis, Davis, CA 95616 john.newman@ars.usda.gov.
National Institutes of Health · USUniversity of California Davis Medical Center · US

Funding

West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Training Program in Biomolecular TechnologyT32GM008799 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI LEACH, J. KENT · 2002 to 2016
$2.4M
NIDDK NIH HHS U24 DK097154NIGMS NIH HHS T32 GM008799
6 · The paper itself

Abstract

Recent advances in analytical and sweat collection techniques provide new opportunities to identify noninvasive biomarkers for the study of skin inflammation and repair. This study aims to characterize the lipid mediator profile including oxygenated lipids, endocannabinoids, and ceramides/sphingoid bases in sweat and identify differences in these profiles between sweat collected from nonlesional sites on the unflared volar forearm of subjects with and without atopic dermatitis (AD). Adapting routine procedures developed for plasma analysis, over 100 lipid mediators were profiled using LC-MS/MS and 58 lipid mediators were detected in sweat. Lipid mediator concentrations were not affected by sampling or storage conditions. Increases in concentrations of C30-C40 [NS] and [NdS] ceramides, and C18:1 sphingosine, were observed in the sweat of study participants with AD despite no differences being observed in transepidermal water loss between study groups, and this effect was strongest in men (P < 0.05, one-way ANOVA with Tukey's post hoc HSD). No differences in oxylipins and endocannabinoids were observed between study groups. Sweat mediator profiling may therefore provide a noninvasive diagnostic for AD prior to the presentation of clinical signs.

Indexed as

AdultBiomarkersCeramidesDermatitis, AtopicEicosanoidsEndocannabinoidsFemaleHumansInflammationLipid MetabolismLipidsMaleMiddle AgedSkinSweatTandem Mass SpectrometryBiomarkersCeramidesEicosanoidsEndocannabinoidsLipidsatopic dermatitisceramidesendocannabinoidsmetabolic profilingnon-invasive samplingoxidized lipidsskinsphingolipids

Identifiers

PMID27875258
PMCPMC5234720
OpenAlexW2552712430

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.